Larsen Mirjam, Kress Wolfram, Schoser Benedikt, Hehr Ute, Müller Clemens R, Rost Simone
Department of Human Genetics, Julius-Maximilians-University, Würzburg, Germany.
Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Eur J Hum Genet. 2016 Oct;24(10):1467-72. doi: 10.1038/ejhg.2016.41. Epub 2016 May 25.
The myotonic dystrophies (DMs) are the most common inherited muscular disorders in adults. In most of the cases, the disease is caused by (CTG)n/(CCTG)n repeat expansions (EXPs) in non-coding regions of the genes DMPK (dystrophia myotonica-protein kinase) and CNBP (CCHC-type zinc-finger nucleic acid-binding protein). The EXP is transcribed into mutant RNAs, which provoke a common pathomechanism that is characterized by misexpression and mis-splicing. In this study, we screened 138 patients with typical clinical features of DM being negative for EXP in the known genes. We sequenced DMPK and CNBP - associated with DM, as well as CELF1 (CUGBP, Elav-like family member 1) and MBNL1 (muscleblind-like splicing regulator 1) - associated with the pathomechanism of DM, for pathogenic variants, addressing the question whether defects in other genes could cause a DM-like phenotype. We identified variants in three unrelated patients in the MBNL1 gene, two of them were heterozygous missense mutations and one an in-frame deletion of three amino acids. The variants were located in different conserved regions of the protein. The missense mutations were classified as potentially pathogenic by prediction tools. Analysis of MBNL1 splice target genes was carried out for one of the patients using RNA from peripheral blood leukocytes (PBL). Analysis of six genes known to show mis-splicing in the skeletal muscle gave no informative results on the effect of this variant when tested in PBL. The association of these variants with the DM phenotype therefore remains unconfirmed, but we hope that in view of the key role of MBNL1 in DM pathogenesis our observations may foster further studies in this direction.
强直性肌营养不良症(DMs)是成人中最常见的遗传性肌肉疾病。在大多数情况下,该疾病由基因DMPK(强直性肌营养不良症蛋白激酶)和CNBP(CCHC型锌指核酸结合蛋白)非编码区的(CTG)n/(CCTG)n重复扩增(EXPs)引起。这种扩增转录为突变RNA,引发一种共同的病理机制,其特征为表达错误和剪接错误。在本研究中,我们筛查了138例具有DM典型临床特征但已知基因中EXP为阴性的患者。我们对与DM相关的DMPK和CNBP以及与DM病理机制相关的CELF1(CUGBP,Elav样家族成员1)和MBNL1(肌肉盲样剪接调节因子1)进行测序,以寻找致病变异,探讨其他基因缺陷是否会导致类似DM的表型。我们在三名无关患者的MBNL1基因中鉴定出变异,其中两个是杂合错义突变,一个是三个氨基酸的框内缺失。这些变异位于该蛋白的不同保守区域。预测工具将错义突变分类为潜在致病性。使用外周血白细胞(PBL)的RNA对其中一名患者进行了MBNL1剪接靶基因分析。对已知在骨骼肌中显示剪接错误的六个基因进行分析,在PBL中测试时,该变异的影响未得出有意义的结果。因此,这些变异与DM表型的关联仍未得到证实,但鉴于MBNL1在DM发病机制中的关键作用,我们希望我们的观察结果能促进这方面的进一步研究。